Endocrine, metabolic, nutritional, and toxic disorders leading to dementia

Annals of Indian Academy of Neurology

Volumn 13, Issue SUPPL. 2, 2010, Pages

  Ghosh, Amitabha ^a  

^a Apollo Gleneagles Hospital   (India)

Author keywords

Dementia; endocrine; metabolic; nutritional; reversible dementia; toxins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ARSENIC; CARBAMAZEPINE; LEAD; LITHIUM; MERCURY; PHENOBARBITAL; PHENYTOIN; PROTIRELIN; THYROTROPIN; TOLUENE; VALPROIC ACID; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; BRAIN RADIATION; CARBON MONOXIDE INTOXICATION; CEREBROTENDINOUS XANTHOMATOSIS; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; CORTICOSTEROID THERAPY; CREUTZFELDT JAKOB DISEASE; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; HASHIMOTO ENCEPHALOPATHY; HEAD INJURY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KORSAKOFF PSYCHOSIS; LACTIC ACIDOSIS; MARCHIAFAVA BIGNAMI DISEASE; METABOLIC DISORDER; METACHROMATIC LEUKODYSTROPHY; MITOCHONDRIAL ENCEPHALOMYOPATHY; NERVE CELL NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITIONAL DISORDER; PELLAGRA; REVIEW; WERNICKE ENCEPHALOPATHY;

EID: 78650962309     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.74247     Document Type: Review

References (70)

1. Smith JS, Kiloh LG. The investigation of dementia: Results in 200 consecutive admissions. Lancet 1981;1:824-7.
2. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998;158:1413-8.
3. Van Boxtel MP, Menheere PP, Bekers O, Hogervorst E, Jolles J. Thyroid function, depressed mood, and cognitive performance in older individuals: The Maastricht Aging Study. Psychoneuroendocrinology 2004;29:891-8.
4. Wahlin A, Bunce D, Wahlin TR. Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology 2005;30:625-37.
5. Roberts LM, Pattison H, Roalfe A, Franklin J, Wilson S, Hobbs FD, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 2006;145:573-81.
6. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-9.
7. Tan ZS, Beiser A, Vasan RS, Au R, Aurebach S, Kiel DP, et al. Thyroid function and the risk of alzheimer's disease: The framingham study. Arch Intern Med 2008;168:1514-20.
8. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MB. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol 2000;53:733-7.
9. Luo L, Yano N, Mao Q, Jackson IM, Stopa EG. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 2002;4:97-103.
10. de Jong FJ, den Heijer T, Visser TJ, Yolanda BD, Drexhage HA, Hofman A, et al. Thyroid Hormones, Dementia, and Atrophy of the Medial Temporal Lobe. J Clin Endocrinol Metab 2006;91:2569-73.
11. Srikanth S, Nagaraja AV. A prospective study of reversible dementias: Frequency, causes, clinical profile and results of treatment. Neurol India 2005;53:291-6.
12. Brain L, Jellinek E, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966;2:512-4.
13. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006;63:197-202.
14. Brown ES, Woolston J, Frol A, Bobadilla L, Khan DA, Hanczyc M, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry 2004;55:538-45.
15. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756-65.
16. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72.
17. Auer RN, Sutherland GR. Hypoxia and related conditions. In Graham DI, Lantos PL, editors. Greenfield's Neuropathology. 7th ed. London: Arnold; 2002. p. 233-80.
18. Choi IS. Delayed neurologic sequelae in carbon monoxide intoxication. Arch Neurol 1983;40:433-5.
19. Min SK. A brain syndrome associated with delayed neuropsychiatric sequelae following acute carbon monoxide intoxication. Acta Psychiatr Scand 1986;73:80-6.
20. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol 2009;28:5-16.
21. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-21.
22. Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984;86:1421-7.
23. Stewart CA, Enders FT, Schneider N, Felmlee-Devine D, Kamath PS, Smith GE. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy. Liver Int 2010;30:841-9.
24. Victor M, Adams RD, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine 1965;44:345-96.
25. Powell EE, Pender MP, Chalk JB, Parkin PJ, Strong R, Lynch S, et al. Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterol 1990;98:1079-82.
26. Stracciari A, Guarino M, Pazzaglia P, Marchesini G, Pisi P. Acquired hepatocerebral degeneration: Full recovery after liver transplantation. J Neurol Neurosurg Psychiatry 2001;70:136-7.
27. Seliger SL, Siscovick DS, Stehman-Breen CO, Gillen DL, Fitzpatrick A, Bleyer A, et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol 2004;15:1904-11.
28. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden. Adv Chronic Kidney Dis 2008;15:123-32.
29. Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol 2009;5:542-51.
30. Griva K, Thompson D, Jayasena D, Davenport A, Harrison M, Newman SP. Cognitive functioning pre-to postkidney transplantation: A prospective study. Nephrol Dial Transplant 2006;21:3275-82.
31. Kemp S, Wanders RJ. X-linked adrenoleukodystrophy: Very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007;90:268-76.
32. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818-23.
33. Cafferty MS, Lovelace RE, Hays AP, Servidei S, Dimauro S, Rowland LP. Polyglucosan body disease. Muscle Nerve 1991;14:102-7.
34. Klein CJ, Boes CJ, Chapin JE, Lynch CD, Campeau NG, Dyck PJ, et al. Adult polyglucosan body disease: Case description of an expanding genetic and clinical syndrome. Muscle Nerve 2004;29:323-8.
35. Samenuk P, Koffman BM. Chenodeoxycholic treatment of cerebrotendinous xanthomatosis. Neurology 2001;56:695.
36. Rathbun JK. Neuropsychological aspects of Wilson's disease. Int J Neurosci 1996;85:221-9.
37. Rosselli M, Lorenzana P, Rosselli A, Vergara I. Wilson's disease, a reversible dementia: Case report. J Clin Exp Neuropsychol 1987;9:399-406.
38. Lauterbach EC, Cummings JL, Duffy J, Coffey CE, Kaufer D, Lovell M, et al. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: A review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases: A report of the ANPA Committee on Research: American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 1998;10:249-66.
39. Cummings JL. Clinical Neuropsychiatry. Orlando, FL: Grune and Stratton; 1985. p. 154.
40. Lpez-Villegas D, Kulisevsky J, Deus J, Junqu C, Pujol J, Guardia E, et al. Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Arch Neurol 1996;53:251-6.
41. Konig P. Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 1989;25:459-68.
42. Shibayama H, Kobayashi H, Nakagawa M, Yamada A, Iwata H, Iwai K, et al. Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clin Neuropathol 1992;11:237-50.
43. Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome and related neurological disorders due to Alcoholism and Malnutrition. 2 nd ed. Philadelphia: Davis; 1989.
44. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004;17:371-83.
45. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, et al. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr 2007;86:1384-91.
46. Gerhardsson L, Lundh T, Minthon L, Londos E. Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008;25:508-15.
47. Mutter J, Naumann J, Schneider R, Walach H. Mercury and Alzheimer's disease. Fortschr Neurol Psychiatr 2007;75:528-38.
48. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, et al. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Perspect 2000;108:393-7.
49. Chakraborti D, Das B, Rahman MM, Chowdhury UK, Biswas B, Goswami AB, et al. Status of groundwater arsenic contamination in the state of West Bengal, India: A 20-year study report. Mol Nutr Food Res 2009;53:542-51.
50. Eicher T, Avery E. Toxic encephalopathies. Neurol Clin 2005;23:353-76.
51. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 2005;16:106-13.
52. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010;12:87-94.
53. Macdonald A, Briggs K, Poppe M, Higgins A, Velayudhan L, Lovestone S. A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry 2008;23:704-11.
54. Mouldi S, Le Rhun E, Gautier S, Devemy M, Deste A, Defebvre L. Lithium-induced encephalopathy mimicking Creutzfeldt-Jakob disease. Rev Neurol (Paris) 2006;162:1118-21.
55. Takahashi M, Hashimoto S, Suenaga T, Nakamura M, Takahashi K. Creutzfeldt-Jakob like syndrome due to lithium intoxication: A case report. Rinsho Shinkeigaku 1997;37338-40.
56. Primavera A, Brusa G, Poeta MG. A Creutzfeldt-Jakob like syndrome due to lithium toxicity. J Neurol Neurosurg Psychiatry 1989;52:423.
57. Delva NJ, Hawken ER. Preventing lithium intoxication. Guide for physicians. Can Fam Physician 2001;47:1595-600.
58. Teepker M, Hamer HM, Knake S, Bandmann O, Oertel WH, Rosenow F. Myoclonic encephalopathy caused by chronic bismuth abuse. Epileptic Disord 2002;4:229-33.
59. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002;17:367-73.
60. Wadzinski J, Franks R, Roane D, Bayard MJ. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med 2007;20:499-502.
61. Mehndiratta MM, Mehndiratta P, Phul P, Garg SA. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE): A study from tertiary care referral university hospital, north India. J Pak Med Assoc 2008;58:627-31.
62. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96.
63. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-42
64. Brown PD, Buckner JC, Uhm JH, Shaw EG. The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro Oncol 2003;5:161-7.
65. Taylor BV, Buckner JC, Cascino TL, O'Fallon JR, Schaefer PL, Dinapoli RP, et al. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 1998;16:2195-201.
66. Kurland LT, Mulder DW. Epidemiologic investigations of ALS: I. Preliminary report on geographic distribution, with special reference to Marianas islands, including clinical and pathologic observations. Neurology 1954;4:355-78.
67. Hirano A, Kurland LT, Krooth RS, Lessel S. Parkinsonism-dementia complex, an endemic disease on the island of Guam: I. Clinical features. Brain 1961;84:642-61.
68. Cox PA, Sacks OW. Cycad neurotoxin, consumption of flying foxes, and ALS/PDC disease in Guam. Neurology 2002;58:956-9.
69. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology 2002;58:90-7.
70. Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, et al. Prevalence of dementia in Chamorros on Guam: Relationship to age, gender, education, and APOE. Neurology 2007;68:1772-81.